Washington, July 9 -- Rep. Mike Kelly issued the following press release:
WASHINGTON, D.C. -- Today, U.S. Rep. Mike Kelly (R-PA) applauded news from the Centers for Medicare and Medicaid Services (CMS) announcing eligible Medicare beneficiaries may now get certain GLP-1 medications for $50 per month through the Medicare GLP-1 Bridge. The new CMS initiative is designed to expand access to innovative treatments and test the impacts of increased access to GLP-1 drugs for weight management on the Medicare program
Kelly leads theTreat and Reduce Obesity Act (TROA)in the U.S. House of Representatives. This bipartisan legislation aims to combat the obesity crisis in the United States by expanding coverage of new health care specialists and chroni...